Search results

Narrow your search

Result types
Article type
Jurisdiction

Showing 41 - 50 of 53

News & Analysis

2018 firm rankings and individuals are now live

25 September 2018 by LMG Life Sciences

New content includes national firm rankings, life sciences stars and editorial reviews

News & Analysis

Top firms and attorneys honored at the 6th annual LMG Life Sciences Awards

13 September 2018 by LMG Life Sciences

Attorneys from across the US and Canada gathered on Sept. 12 at New York’s Essex House

News & Analysis

LMG Life Sciences Awards 2018 – shortlists announced

03 August 2018 by LMG Life Sciences

LMG Life Sciences Awards 2018 – shortlists announced

News & Analysis

Research begins for LMG Life Sciences 2018

12 April 2018 by LMG Life Sciences

Legal Media Group has officially launched the 2018 LMG Life Sciences research cycle

News & Analysis

Canada in-depth introduction

29 September 2017 by Nicholas McIsaac

News & Analysis

Top attorneys meet for the 2017 LMG Life Sciences Awards

14 September 2017 by LMG Life Sciences

Top attorneys meet for the 2017 LMG Life Sciences Awards

News & Analysis

Beyond Biosimilarity: Draft Guidance for Demonstrating Biological Interchangeability

06 September 2017 by LMG Life Sciences

The primary focus of the Food and Drug Administrationtion, industry and counsel preparing for the advent of follow-on biologics in the United States has been the legal and regulatory framework ...

News & Analysis

Licensing tips from a patent litigator

06 September 2017 by LMG Life Sciences

Anyone drafting patent license agreements should follow several tips in order to avoid or better prepare for litigation later on, says Jessamyn Berniker of Williams & Connolly.

News & Analysis

To Modify or Not to Modify, That is the Question

06 September 2017 by LMG Life Sciences

In IPRs regarding the patents to pharmaceutical compounds, patentability often turns on the obviousness of taking a known compound and modifying it based on a known technique.

News & Analysis

CFAD Fails to Knock Out 4 Acorda Patents to Multiple Sclerosis Drug

29 August 2017 by LMG Life Sciences

A recent set of final written decisions in four IPRs against Acorda Therapeutics puts more marks in the loss column for Kyle Bass and the Coalition for Affordable Drugs.